196 related articles for article (PubMed ID: 16509582)
21. Kinetic analysis of human serine/threonine protein phosphatase 2Calpha.
Fjeld CC; Denu JM
J Biol Chem; 1999 Jul; 274(29):20336-43. PubMed ID: 10400656
[TBL] [Abstract][Full Text] [Related]
22. Activity of PP2C beta is increased by divalent cations and lipophilic compounds depending on the substrate.
Krieglstein J; Selke D; Maassen A; Klumpp S
Methods Enzymol; 2003; 366():282-9. PubMed ID: 14674255
[No Abstract] [Full Text] [Related]
23. Optimization of a cyclic peptide inhibitor of Ser/Thr phosphatase PPM1D (Wip1).
Hayashi R; Tanoue K; Durell SR; Chatterjee DK; Jenkins LM; Appella DH; Appella E
Biochemistry; 2011 May; 50(21):4537-49. PubMed ID: 21528848
[TBL] [Abstract][Full Text] [Related]
24. The catalytic role of the M2 metal ion in PP2Cα.
Pan C; Tang JY; Xu YF; Xiao P; Liu HD; Wang HA; Wang WB; Meng FG; Yu X; Sun JP
Sci Rep; 2015 Feb; 5():8560. PubMed ID: 25708299
[TBL] [Abstract][Full Text] [Related]
25. Is RK-682 a promiscuous enzyme inhibitor? Synthesis and in vitro evaluation of protein tyrosine phosphatase inhibition of racemic RK-682 and analogues.
Carneiro VM; Trivella DB; Scorsato V; Beraldo VL; Dias MP; Sobreira TJ; Aparicio R; Pilli RA
Eur J Med Chem; 2015 Jun; 97():42-54. PubMed ID: 25938987
[TBL] [Abstract][Full Text] [Related]
26. Two-track virtual screening approach to identify both competitive and allosteric inhibitors of human small C-terminal domain phosphatase 1.
Park H; Lee HS; Ku B; Lee SR; Kim SJ
J Comput Aided Mol Des; 2017 Aug; 31(8):743-753. PubMed ID: 28653253
[TBL] [Abstract][Full Text] [Related]
27. Role of type 2C protein phosphatases in growth regulation and in cellular stress signaling.
Lammers T; Lavi S
Crit Rev Biochem Mol Biol; 2007; 42(6):437-61. PubMed ID: 18066953
[TBL] [Abstract][Full Text] [Related]
28. Substrate-dependent metal preference of PPM1H, a cancer-associated protein phosphatase 2C: comparison with other family members.
Sugiura T; Noguchi Y
Biometals; 2009 Jun; 22(3):469-77. PubMed ID: 19262998
[TBL] [Abstract][Full Text] [Related]
29. Phoslactomycin targets cysteine-269 of the protein phosphatase 2A catalytic subunit in cells.
Teruya T; Simizu S; Kanoh N; Osada H
FEBS Lett; 2005 Apr; 579(11):2463-8. PubMed ID: 15848189
[TBL] [Abstract][Full Text] [Related]
30. Protein phosphatase 2C inactivates F-actin binding of human platelet moesin.
Hishiya A; Ohnishi M; Tamura S; Nakamura F
J Biol Chem; 1999 Sep; 274(38):26705-12. PubMed ID: 10480873
[TBL] [Abstract][Full Text] [Related]
31. Discovery of small molecule inhibitors of the PH domain leucine-rich repeat protein phosphatase (PHLPP) by chemical and virtual screening.
Sierecki E; Sinko W; McCammon JA; Newton AC
J Med Chem; 2010 Oct; 53(19):6899-911. PubMed ID: 20836557
[TBL] [Abstract][Full Text] [Related]
32. Insights into the catalytic mechanism of PPM Ser/Thr phosphatases from the atomic resolution structures of a mycobacterial enzyme.
Bellinzoni M; Wehenkel A; Shepard W; Alzari PM
Structure; 2007 Jul; 15(7):863-72. PubMed ID: 17637345
[TBL] [Abstract][Full Text] [Related]
33. Allosteric Wip1 phosphatase inhibition through flap-subdomain interaction.
Gilmartin AG; Faitg TH; Richter M; Groy A; Seefeld MA; Darcy MG; Peng X; Federowicz K; Yang J; Zhang SY; Minthorn E; Jaworski JP; Schaber M; Martens S; McNulty DE; Sinnamon RH; Zhang H; Kirkpatrick RB; Nevins N; Cui G; Pietrak B; Diaz E; Jones A; Brandt M; Schwartz B; Heerding DA; Kumar R
Nat Chem Biol; 2014 Mar; 10(3):181-7. PubMed ID: 24390428
[TBL] [Abstract][Full Text] [Related]
34. Exploration of new drug-like inhibitors for serine/threonine protein phosphatase 5 of Plasmodium falciparum: a docking and simulation study.
Gupta S; Jadaun A; Kumar H; Raj U; Varadwaj PK; Rao AR
J Biomol Struct Dyn; 2015; 33(11):2421-41. PubMed ID: 25967133
[TBL] [Abstract][Full Text] [Related]
35. A potent and selective inhibitor for the UBLCP1 proteasome phosphatase.
He Y; Guo X; Yu ZH; Wu L; Gunawan AM; Zhang Y; Dixon JE; Zhang ZY
Bioorg Med Chem; 2015 Jun; 23(12):2798-809. PubMed ID: 25907364
[TBL] [Abstract][Full Text] [Related]
36. Theoretical models of catalytic domains of protein phosphatases 1 and 2A with Zn2+ and Mn2+ metal dications and putative bioligands in their catalytic centers.
Woźniak-Celmer E; Ołdziej S; Ciarkowski J
Acta Biochim Pol; 2001; 48(1):35-52. PubMed ID: 11440182
[TBL] [Abstract][Full Text] [Related]
37. Focused library with a core structure extracted from natural products and modified: application to phosphatase inhibitors and several biochemical findings.
Hirai G; Sodeoka M
Acc Chem Res; 2015 May; 48(5):1464-73. PubMed ID: 25894598
[TBL] [Abstract][Full Text] [Related]
38. Identification of protein phosphatase 2C and confirmation of other protein phosphatases in the ocular lenses.
Umeda IO; Nakata H; Nishigori H
Exp Eye Res; 2004 Dec; 79(6):385-92. PubMed ID: 15669140
[TBL] [Abstract][Full Text] [Related]
39. Substrate analysis of Arabidopsis PP2C-type protein phosphatases.
Umbrasaite J; Schweighofer A; Meskiene I
Methods Mol Biol; 2011; 779():149-61. PubMed ID: 21837565
[TBL] [Abstract][Full Text] [Related]
40. Purification and characterization of the catalytic subunit of protein phosphatase 1 from Neurospora crassa.
Szöór B; Dombrádi V; Gergely P; Fehér Z
Acta Biol Hung; 1997; 48(3):289-302. PubMed ID: 9406609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
